Latest editorial
Pfizer-BioNTech vaccine
VACCINE equity campaigners slammed Pfizer’s “profiteering” during a pandemic today after the company increased Covid-19 vaccine prices for the NHS.
Britain will reportedly pay £1 billion for 35 million doses of Pfizer’s vaccine for “booster” jabs next year, with prices increasing a fifth from £18 to £22 a dose.
Global Justice Now warned that by ordering millions of “overpriced” booster jabs, Britain is sending low and middle-income countries who are struggling to access vaccines to the back of the queue.
Fertiliser chaos triggered by Gulf conflict could send prices soaring and leave millions facing devastating hunger, writes DYLAN MURPHY
Politicians who continue to welcome contracts with US companies without considering the risks and consequences of total dependency in the years to come are undermining the raison d’etre of the NHS, argues Dr JOHN PUNTIS
While ordinary Americans were suffering in the wake of 2005’s deadly hurricane, the Bush administration was more concerned with maintaining its anti-Cuba stance than with saving lives, writes MANOLO DE LOS SANTOS